Synthetic Biology Market: Growth, Size, Share, and Trends

Report Code BT 2910
Published in Nov, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029

Overview

The global synthetic biology market, valued at US$11.97 billion in 2023, is forecasted to grow at a robust CAGR of 20.6%, reaching US$12.33 billion in 2024 and an impressive US$31.52 billion by 2029. Rising demand for bio-based products, growing demand for personalized therapies, especially in gene and cell therapies, and advancements in DNA sequencing and synthesis technologies are some of the factors accelerating the market growth. Additionally, synthetic biology is driving innovations in biopharmaceutical production and increased use of synthetic biology in agriculture is further fueling the growth of the synthetic market.

Attractive Opportunities in the Synthetic Biology Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the growing collaborations in the field of synthetic biology, growing partnerships in the Chinese market, and investments in Asia Pacific countries for research.

The increasing demand for bio-based products and rising funding in R&D & collaborations fuel the expansion of the synthetic biology market significantly.

Growing opportunities in agricultural synthetic biology and use of AI and ML are expected to provide lucrative opportunities for market players.

The Asia Pacific synthetic biology market is expected to grow at CAGR of 22.1% during the forecast period.

Cost constraints and product scalability raise challenges to market growth.

Global Synthetic Biology Market Dynamics

DRIVER: Diverse applications of synthetic biology

Synthetic biology comprises biological systems engineering for practical purposes using tools from biology, engineering, and computer science. This interdisciplinary approach has encouraged innovation across various sectors in pharmaceuticals and medicine (semi-synthetic drugs, vaccines, and disease mechanisms).

The market is experiencing rapid growth, primarily driven by diverse applications of synthetic biology in healthcare, agriculture, environmental science, and industrial biotechnology. Synthetic biology enables the creation of custom-designed organisms, empowering industries to solve complex challenges and unlock new revenue streams. Agriculture benefits from synthetic biology's ability to engineer crops with enhanced resilience to climate change and increased yields, supporting food security. Pivot Bio’s nitrogen-producing microbial product for corn and wheat fields exemplifies innovation in sustainable agriculture, enabling farmers to reduce dependence on synthetic fertilizers and minimize environmental impact. Moreover, synthetic biology's applications in producing bio-based materials and bioplastics address environmental concerns, aligning with the circular economy.

Key market players operating in the market focus on collaboration and partnerships with an aim to cater to diversified applications is further likely to propel the market growth. For instance, in September 2024, Gingko Bioworks and NOVUS International entered into a partnership to develop advanced feed additives in order to meet o meet the evolving needs of the animal agriculture industry.

RESTRAINT: Production scalability

The intricacy of engineering biological systems is a primary barrier to scalability in synthetic biology. Designing and optimizing genetic pathways, metabolic processes, and microbial hosts for large scale production mostly requires vast trial and error, as biological systems may behave unpredictably in various environmental conditions. For example, while a microbial strain may perform well in a controlled laboratory setting, it may encounter challenges when scaled up in bioreactors due to challenges like nutrient availability, oxygen transfer, and product toxicity.

Another significant barrier is the variability and reproducibility of biological systems. In contrast to traditional chemical processes, biological systems show inherent variability caused by genetic mutations, environmental influences, and microbial interactions. Executing consistent product quality and yield across large-scale production runs necessitates robust monitoring, control strategies, and adaptive management practices.

 

OPPORTUNITY: Growing use of artificial intelligence and machine learning

In recent years, AI/ML has emerged as a plausible alternative to systems biology for the elucidation of biological phenomena and in attaining specified design objectives in synthetic biology. The current development of AI and ML techniques and tools in the biological and biotechnological domains can be viewed similarly for bringing about smarter and more automated analysis and decision-making in these fields. AI/ML remains an alternative for investigating system behaviors and improving the output of interest in synthetic biology applications. Currently, various market players shifted the focus to machine learning use in synthetic biology. This is likely to create lucrative growth opportunities in the coming years. For instance, in November 2022, BigHat Biosciences, Inc., a biotechnology company with a ML-guided antibody discovery and development platform, collaborated with Merck to develop an AI-enabled platform to expedite protein engineering to design and develop novel therapeutic candidates. Under the collaboration, BigHat and Merck were expected to collaborate to optimize up to three proteins by leveraging BigHat’s platform to synthesize, express, purify, and characterize molecules. In October 2021, LabGenius, a pioneer in the use of ML for antibody engineering, received a SMART grant of USD 27 million (GBP 25 million) from Innovate UK.

CHALLENGES: Cost constraints

Synthetic biology encounters obstacles in achieving cost competitiveness compared to established petrochemical and agricultural processes. During the initial production stage, the cost of growth media takes up a large part of the total costs, with downstream processing costs occasionally surpassing half of the total expenses. An important aspect leading to the expense of growth media is the carbon source, which is usually obtained from crops such as corn or sugar cane, causing worries about the sustainability of costs and potential effects on food supply security.

Recent studies are concentrating on creating synthetic biology methods that use cheaper carbon sources like lignocellulosic waste or C1 compounds such as captured CO2 from industrial activities. These developments aim to lower expenses and elevate Synthetic biology's role in the circular economy. Products derived from C1 carbon sources, like ethanol from Lanzatech and Solein protein from Solar Food, are nearing readiness for commercial use. Minimizing expenses for growth involves using host organisms which can survive in cheaper environments, like halophiles that flourish in seawater. Wild Microbes and other companies are currently researching these microorganisms to improve the efficiency of biomanufacturing processes.

Global Synthetic Biology Market Ecosystem Analysis

The synthetic biology market operates within an ecosystem comprising a wide range of stakeholders playing a vital role in designing and adopting synthetic biology. This ecosystem comprises synthetic biology products/services providers, regulatory bodies, and end users. The key market players include companies operating in the synthetic biology market for several years with extensive product portfolios, vigorous global sales, and marketing networks.

 

Oligonucleotides & synthetic DNA dominated the synthetic biology market in 2023.

Based on tool, the synthetic biology market is segmented into chassis organisms, enzymes, oligonucleotides & synthetic DNA, cloning technology kits, xeno nucleic acids, and synthetic cells. The oligonucleotides & synthetic DNA segment dominated the market in 2023. The growing adoption of gene-editing tools in therapeutic development and agricultural biotechnology drives demand for synthetic DNA and oligonucleotides. The launch of new products by key market players and startup players is further likely to propel the market growth in coming years.

The medical application segment is likely to grow at a significant CAGR during the forecast period.

Based on application, the synthetic biology market is categorized into medical applications; industrial applications; food, animal health and agriculture applications; and environmental applications. The medical applications segment accounted for the largest share of the synthetic biology market, followed by the industrial applications segment. The large share of the segment is owing to increased use of synthetic biology in pharmaceutical field such as drug discovery, personalized medicine, diagnostics, and cell and gene therapy, among others. Recent collaborations and product launches are likely to contribute to the momentum in this segment.

North America was the largest regional market for synthetic biology in 2023.

Based on region, the synthetic biology market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global synthetic biology market and is expected to maintain a leading market share during the forecast period.

The Asia Pacific synthetic biology market is anticipated to grow at a significant CAGR during the forecast period. The growth in research activities and biologic therapeutics manufacturing is likely to surge the market growth in the region. Furthermore, high-growth regions such as China, Japan, Australia, and Singapore are expected to be major contributors to the Asia Pacific synthetic biology market. The markets for biologics such as antibodies and protein-based drugs are also on the rise in the Asia Pacific region. Biotechnology-based drugs are anticipated to be one of the key drivers for the research industry due to increased research and government funds provided for these drugs.

HIGHEST CAGR MARKET IN 2024-2029
US FASTEST GROWING MARKET IN THE REGION

Recent Developments of Synthetic Biology Market

  • In May 2024, Merck signed a Memorandum of Understanding (MOU) with the Korea Advanced Institute of Science and Technology (KAIST) aimed at advancing the research and development ecosystem in South Korea for industrial applications.
  • In May 2024, Integrated DNA Technologies (IDT) expanded synthetic biology operations with the opening of a new site. The new site is dedicated to manufacturing IDT’s synthetic biology products.
  • In May 2024, Merck signed a Memorandum of Understanding (MOU) with the Korea Advanced Institute of Science and Technology (KAIST) aimed at advancing the research and development ecosystem in South Korea for industrial applications.
  • In February 2023, Agilent Technologies Inc. launched an on-deck thermal cycler (ODTC) that combined with the Agilent Bravo NGS automated liquid handling platform for next-generation sequencing (NGS), end-point PCR, and cell-based applications.

Key Market Players

KEY PLAYERS IN THE SYNTHETIC BIOLOGY MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Synthetic Biology Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered Tools, Technology and Application
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Questions Addressed by the Report

The global synthetic biology market is projected to grow from USD 12.33 billion in 2024 to USD 31.52 billion in 2029, demonstrating a robust CAGR of 20.6%.
The key drivers of the synthetic biology market include the rising demand for bio-based products, advancements in DNA sequencing, personalized therapies, and innovations in biopharmaceutical production and agricultural biotechnology.
North America led the synthetic biology market in 2023 and is expected to maintain a dominant market share during the forecast period, driven by high research activities and investments.
The key applications of synthetic biology include healthcare, agriculture, environmental science, and industrial biotechnology, with medical applications such as drug discovery and personalized medicine leading the market.
The growing adoption of AI and machine learning in synthetic biology is expected to drive market growth by enabling smarter biological design, enhancing efficiency, and creating new therapeutic candidates.
The primary challenges in synthetic biology include scalability issues, cost constraints, and the inherent variability of biological systems which affects reproducibility and product quality at scale.
Opportunities in synthetic biology lie in the growing use of artificial intelligence, expanding applications in agriculture, food security, and the development of sustainable bio-based materials and bioplastics.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Synthetic Biology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
45
RESEARCH METHODOLOGY
49
EXECUTIVE SUMMARY
61
PREMIUM INSIGHTS
65
MARKET OVERVIEW
68
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Diverse applications of synthetic biology
    - Surging demand for bio-based products
    - Advancements in synthetic biology
    - Increasing funding in R&D and collaborations
    RESTRAINTS
    - Production scalability
    - Ethical and regulatory challenges
    OPPORTUNITIES
    - Rising opportunities for agricultural synthetic biology
    - Growing integration of artificial intelligence and machine learning
    CHALLENGES
    - Cost constraints
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    PRODUCT/SERVICE PROVIDERS
    END USERS
    REGULATORY LANDSCAPE
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - DNA synthesis and sequencing
    - Gene editing tools
    - Bioinformatics and computational tools
    - Nanotechnology
    COMPLEMENTARY TECHNOLOGIES
    - Cellular and tissue engineering
    ADJACENT TECHNOLOGIES
    - Metabolic engineering
  • 5.7 PATENT ANALYSIS
    METHODOLOGY
    NUMBER OF PATENTS FILED
    INNOVATION AND PATENT APPLICATIONS
  • 5.8 PRICING ANALYSIS
    INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER
    INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION
  • 5.9 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.10 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.11 INVESTMENT & FUNDING SCENARIO
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY BUYING CRITERIA
  • 5.14 IMPACT OF AI ON SYNTHETIC BIOLOGY MARKET
SYNTHETIC BIOLOGY MARKET, BY TOOL
104
  • 6.1 INTRODUCTION
  • 6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
    SURGING DEMAND FOR SYNTHETIC GENES TO SUPPORT MARKET GROWTH
  • 6.3 ENZYMES
    WIDE POTENTIAL OF ENZYME ENGINEERING IN OMICS STUDIES TO PROPEL MARKET
  • 6.4 CLONING TECHNOLOGY KITS
    ALTERATION AND OPTIMIZATION OF GENETIC CIRCUIT DESIGNS BY MOLECULAR BIOLOGY TECHNIQUES TO DRIVE MARKET
  • 6.5 SYNTHETIC CELLS
    GROWING POPULARITY OF SYNTHETIC CELLS AS SUBSTITUTES FOR NATURAL CELLS TO BOOST MARKET GROWTH
  • 6.6 CHASSIS ORGANISMS
    INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET
  • 6.7 XENO NUCLEIC ACIDS
    SPIKE IN DEMAND FOR BREAKTHROUGH MEDICINES TO AID MARKET GROWTH
SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY
128
  • 7.1 INTRODUCTION
  • 7.2 GENE SYNTHESIS
    RISING DEMAND FOR SYNTHETIC GENES AND INCREASING COMPETITIVENESS AMONG MARKET PLAYERS TO SPUR MARKET GROWTH
  • 7.3 GENOME ENGINEERING
    SURGING NEED FOR RAPID, CHEAP, AND MULTIPLEX MODIFICATION OF GENOMES TO DRIVE MARKET
  • 7.4 SEQUENCING
    RISING ADOPTION OF SEQUENCING TECHNOLOGY TO BOOST MARKET GROWTH
  • 7.5 BIOINFORMATICS
    INCREASING ADVANCEMENTS AND RISING USE OF BIOINFORMATICS TO PROPEL MARKET GROWTH
  • 7.6 CLONING
    PRECISE GENETIC REPLICATION TO ACCELERATE RESEARCH AND SCALING APPLICATIONS ACROSS VARIOUS INDUSTRIES
  • 7.7 SITE-DIRECTED MUTAGENESIS
    WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET
  • 7.8 MEASUREMENT & MODELING
    INCREASING DEMAND FOR CELL-FREE SYNTHETIC BIOLOGY TO FOSTER MARKET GROWTH
  • 7.9 MICROFLUIDICS
    RISING FOCUS ON INCREASING SCALABILITY OF SYNTHETIC BIOLOGY TOOLS TO PROPEL MARKET GROWTH
  • 7.10 NANOTECHNOLOGY
    CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY TO AID MARKET GROWTH
SYNTHETIC BIOLOGY MARKET, BY APPLICATION
163
  • 8.1 INTRODUCTION
  • 8.2 MEDICAL APPLICATIONS
    PHARMACEUTICALS
    - Potential of synthetic biology techniques in development of active pharmaceutical ingredients to drive market
    DRUG DISCOVERY & THERAPEUTICS
    - Cancer detection & diagnostics
    - Other drug discovery & therapeutic applications
    ARTIFICIAL TISSUE & TISSUE REGENERATION
    - Biosynthesis
    - Stem cell regulation
    - Other artificial tissue & tissue regeneration applications
  • 8.3 INDUSTRIAL APPLICATIONS
    BIOFUELS & RENEWABLE ENERGY
    - Advantages of using genetically engineered organisms for synthetic production of biofuels to propel market growth
    INDUSTRIAL ENZYMES
    - Textile industry
    - Paper industry
    - Consumer care industry
    - Other industries
    BIOMATERIALS & GREEN CHEMICALS
    - Production of green chemicals through microbial fermentation to drive market
  • 8.4 FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
    FLAVORS & FRAGRANCES
    - Rising demand for natural, sustainable products to bolster market growth
    OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
  • 8.5 ENVIRONMENTAL APPLICATIONS
    BIOREMEDIATION
    - Increasing need for cost-effective, on-site environmental monitoring methods to boost market
    BIOSENSING
    - Growing interest in development of whole-cell biosensors to drive market
SYNTHETIC BIOLOGY MARKET, BY REGION
257
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    - Rising investment in synthetic biology companies and surging demand for bio-based products to drive market
    CANADA
    - Strong research infrastructure and availability of funding to support market growth
  • 9.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    - Government initiatives and increasing funding to propel market growth
    UK
    - Increasing R&D expenditure to favor market growth
    FRANCE
    - Investments aimed at increasing research in various biomedical fields to augment market growth
    SWITZERLAND
    - Established biotech ecosystem, strong academic institutions, and favorable government policies to favor market growth
    DENMARK
    - Presence of third-largest commercial drug development pipeline in Europe to favor market growth
    ITALY
    - Increasing life sciences R&D funded by both public and private organizations to foster market
    SPAIN
    - Well-established network of research centers, universities, and hospitals to support market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    CHINA
    - Rising growth opportunities for pharmaceutical and biopharmaceutical companies to drive market
    JAPAN
    - Growing awareness of synthetic biology's importance and potential applications to accelerate market growth
    INDIA
    - Increasing R&D activities and government funding initiatives to bolster market growth
    AUSTRALIA
    - Increasing funding for synthetic biology research to accelerate market growth
    SOUTH KOREA
    - Increasing focus on developing biotechnology and pharmaceutical sectors to boost market
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    - Growing life sciences and pharmaceutical industry to fuel demand for synthetic biological products
    MEXICO
    - Increasing support for biotechnology infrastructure development to augment market growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST
    MIDDLE EAST: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - KSA
    - UAE
    - Rest of GCC countries
    REST OF MIDDLE EAST
  • 9.7 AFRICA
    AFRICA: MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
431
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SYNTHETIC BIOLOGY MARKET
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Tool footprint
    - Technology footprint
    - Application footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS, 2023
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
452
  • 11.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    NOVOZYMES A/S
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/Services offered
    AGILENT TECHNOLOGIES INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    AMYRIS, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    CODEXIS, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    TWIST BIOSCIENCE
    - Business overview
    - Products/Services offered
    - Recent developments
    GENSCRIPT
    - Business overview
    - Products/Services offered
    - Recent developments
    PRECIGEN
    - Business overview
    - Products/Services offered
    GINKGO BIOWORKS
    - Business overview
    - Products/Services offered
    - Recent developments
    VIRIDOS
    - Business overview
    - Products/Services offered
    - Recent developments
    SYNTHEGO
    - Business overview
    - Products/Services offered
    - Recent developments
    CREATIVE ENZYMES
    - Business overview
    - Products/Services offered
    CYRUS BIOTECHNOLOGY
    - Business overview
    - Products/Services offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    ATUM
    TESELAGEN
    ARZEDA
    INTEGRATED DNA TECHNOLOGIES, INC.
    NEW ENGLAND BIOLABS
    ELEVATEBIO
    ZENFOLD (IOSYNTH)
    SYNBIO TECHNOLOGIES
    INSCRIPTA, INC.
    CRISPR THERAPEUTICS
APPENDIX
527
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 SYNTHETIC BIOLOGY MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 4 KEY END USERS IN SYNTHETIC BIOLOGY MARKET
  • TABLE 5 KEY REGULATORY BODIES IN SYNTHETIC BIOLOGY MARKET
  • TABLE 6 NUMBER OF PATENTS FILED IN SYNTHETIC BIOLOGY MARKET, BY DOCUMENT TYPE, 2014–2024
  • TABLE 7 DETAILED ANALYSIS OF KEY PATENTS IN SYNTHETIC BIOLOGY MARKET, 2024
  • TABLE 8 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER, 2023
  • TABLE 9 INDICATIVE PRICING ANALYSIS OF SYNTHETIC BIOLOGY TOOLS, BY REGION, 2023
  • TABLE 10 KEY CONFERENCES & EVENTS, JUNE 2024–DECEMBER 2025
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
  • TABLE 17 SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • TABLE 19 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 20 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 21 SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 22 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 23 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 25 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 64 SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 SYNTHETIC BIOLOGY MARKET FOR CLONING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 128 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY & THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 167 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 174 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 175 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 181 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 188 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 206 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOFUELS & RENEWABLE ENERGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 210 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 211 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 218 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 225 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 233 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 234 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 241 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 246 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 247 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 248 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 251 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 253 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 254 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 255 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 257 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 258 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 260 SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 261 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 262 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 264 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 265 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS & GREEN CHEMICALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 267 SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 269 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 270 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 272 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 275 SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 276 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 277 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 278 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 280 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FLAVORS & FRAGRANCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 282 SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 283 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 285 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 287 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 288 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 289 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 291 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 292 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 295 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 296 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 297 SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 298 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 299 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 301 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 302 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 303 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 304 SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 305 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 306 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 308 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 309 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 310 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 311 SYNTHETIC BIOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 312 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 313 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 314 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 315 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 316 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 319 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 321 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 NORTH AMERICA: KEY MACRO INDICATORS
  • TABLE 325 US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 326 US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 327 US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 328 US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 331 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 333 US: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 US: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 337 CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 338 CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 339 CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 340 CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 341 CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 343 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 344 CANADA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 345 CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 CANADA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 348 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 349 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 350 EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 351 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 353 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 354 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 356 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 EUROPE: KEY MACRO INDICATORS
  • TABLE 360 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 361 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 362 GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 363 GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 364 GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 365 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 366 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 367 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 368 GERMANY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 GERMANY: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 372 UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 373 UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 374 UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 375 UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 376 UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 378 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 379 UK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 380 UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 381 UK: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 382 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 383 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 384 FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 385 FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 386 FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 387 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 388 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 389 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 390 FRANCE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 391 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 392 FRANCE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 393 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 394 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 395 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 396 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 397 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 400 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 401 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 402 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 403 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 405 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 406 DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 407 DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 412 DENMARK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 DENMARK: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 415 ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 416 ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 417 ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 418 ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 421 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 422 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 423 ITALY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 424 ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 425 ITALY: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 426 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 427 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 428 SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 429 SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 430 SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 432 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 433 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 434 SPAIN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 436 SPAIN: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 437 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 438 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 439 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 440 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 441 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 442 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 445 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 446 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 448 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 449 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 450 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 451 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 452 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 453 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 454 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 455 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 456 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 457 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 458 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 ASIA PACIFIC: KEY MACRO INDICATORS
  • TABLE 461 CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 462 CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 463 CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 464 CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 465 CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 466 CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 467 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 468 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 469 CHINA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 470 CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 471 CHINA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 472 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 473 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 474 JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 475 JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 477 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 478 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 480 JAPAN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 481 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 JAPAN: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 483 INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 484 INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 485 INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 486 INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 487 INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 488 INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 489 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 490 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 491 INDIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 492 INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 493 INDIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 495 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 496 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 497 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 498 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 499 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 500 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 501 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 502 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 503 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 505 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 506 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 507 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 508 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 511 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 512 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 513 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 SOUTH KOREA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 516 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 517 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 518 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 519 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 522 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 523 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 524 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 525 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 526 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 527 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 528 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 529 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 530 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 531 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 532 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 534 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 535 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 536 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 537 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 538 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 539 LATIN AMERICA: KEY MACRO INDICATORS
  • TABLE 540 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 541 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 542 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 543 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 544 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 545 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 546 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 547 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 548 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 549 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 550 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 551 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 552 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 553 MEXICO: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 554 MEXICO: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 555 MEXICO: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 556 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 557 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 558 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 559 MEXICO: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 560 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 561 MEXICO: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 562 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 563 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 564 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 565 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 566 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 567 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 568 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 569 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 570 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 571 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 572 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 573 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION)
  • TABLE 574 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 575 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 576 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 577 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 578 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 579 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 580 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 581 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 582 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 583 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 584 MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 585 MIDDLE EAST: KEY MACROINDICATORS
  • TABLE 586 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 587 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 588 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 589 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 590 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 591 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 592 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 593 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 594 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 595 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 596 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 597 GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 598 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 599 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 600 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 601 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 602 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 603 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 604 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 605 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 606 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 607 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 608 SAUDI ARABIA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 609 UAE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 610 UAE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 611 UAE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 612 UAE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 613 UAE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 614 UAE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 615 UAE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 616 UAE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 617 UAE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 618 UAE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 619 UAE: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 620 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 621 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 622 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 623 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 624 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 625 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 626 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 627 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 628 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 629 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 630 REST OF GCC COUNTRIES: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 631 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 632 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 633 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 634 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 635 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 636 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 637 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 638 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 639 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 640 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 641 REST OF MIDDLE EAST: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 642 AFRICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022–2029 (USD MILLION)
  • TABLE 643 AFRICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 644 AFRICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 645 AFRICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 646 AFRICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 647 AFRICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 648 AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 649 AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029 (USD MILLION)
  • TABLE 650 AFRICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 651 AFRICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 652 AFRICA: SYNTHETIC BIOLOGY MARKET FOR FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 653 MACROECONOMIC OUTLOOK FOR SYNTHETIC BIOLOGY MARKET IN AFRICA
  • TABLE 654 SYNTHETIC BIOLOGY MARKET: KEY DEVELOPMENTS OF MAJOR PLAYERS, 2021–2024
  • TABLE 655 SYNTHETIC BIOLOGY MARKET: DEGREE OF COMPETITION
  • TABLE 656 SYNTHETIC BIOLOGY MARKET: REGION FOOTPRINT
  • TABLE 657 SYNTHETIC BIOLOGY MARKET: TOOL FOOTPRINT
  • TABLE 658 SYNTHETIC BIOLOGY MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 659 SYNTHETIC BIOLOGY MARKET: APPLICATION FOOTPRINT
  • TABLE 660 SYNTHETIC BIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 661 SYNTHETIC BIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 662 SYNTHETIC BIOLOGY MARKET: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 663 SYNTHETIC BIOLOGY MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 664 SYNTHETIC BIOLOGY MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 665 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 666 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 667 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 668 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 669 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 670 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 671 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 672 MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 673 NOVOZYMES A/S: COMPANY OVERVIEW
  • TABLE 674 NOVOZYMES A/S: PRODUCTS/SERVICES OFFERED
  • TABLE 675 NOVOZYMES A/S: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 676 NOVOZYMES A/S: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 677 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 678 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 679 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 680 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 681 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 682 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 683 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 684 AMYRIS, INC.: COMPANY OVERVIEW
  • TABLE 685 AMYRIS, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 686 AMYRIS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 687 CODEXIS, INC.: COMPANY OVERVIEW
  • TABLE 688 CODEXIS, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 689 CODEXIS, INC.: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 690 CODEXIS, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 691 CODEXIS, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 692 TWIST BIOSCIENCE: COMPANY OVERVIEW
  • TABLE 693 TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED
  • TABLE 694 TWIST BIOSCIENCE: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 695 TWIST BIOSCIENCE: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 696 TWIST BIOSCIENCE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 697 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 698 GENSCRIPT: PRODUCTS/SERVICES OFFERED
  • TABLE 699 GENSCRIPT: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 700 GENSCRIPT: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 701 GENSCRIPT: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 702 PRECIGEN: COMPANY OVERVIEW
  • TABLE 703 PRECIGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 704 GINKGO BIOWORKS: COMPANY OVERVIEW
  • TABLE 705 GINKGO BIOWORKS: PRODUCTS/SERVICES OFFERED
  • TABLE 706 GINKGO BIOWORKS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 707 GINKGO BIOWORKS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 708 VIRIDOS: COMPANY OVERVIEW
  • TABLE 709 VIRIDOS: PRODUCTS/SERVICES OFFERED
  • TABLE 710 VIRIDOS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 711 VIRIDOS: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 712 VIRIDOS: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 713 SYNTHEGO: COMPANY OVERVIEW
  • TABLE 714 SYNTHEGO: PRODUCTS/SERVICES OFFERED
  • TABLE 715 SYNTHEGO: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 716 SYNTHEGO: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 717 SYNTHEGO: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 718 CREATIVE ENZYMES: COMPANY OVERVIEW
  • TABLE 719 CREATIVE ENZYMES: PRODUCTS/SERVICES OFFERED
  • TABLE 720 CYRUS BIOTECHNOLOGY: COMPANY OVERVIEW
  • TABLE 721 CYRUS BIOTECHNOLOGY: PRODUCTS/SERVICES OFFERED
  • TABLE 722 CYRUS BIOTECHNOLOGY: DEALS, JANUARY 2021–SEPTEMBER 2024
LIST OF FIGURES
 
  • FIGURE 1 SYNTHETIC BIOLOGY MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARIES: SYNTHETIC BIOLOGY MARKET
  • FIGURE 4 SYNTHETIC BIOLOGY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 SYNTHETIC BIOLOGY MARKET: CAGR PROJECTION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF SYNTHETIC BIOLOGY MARKET (2024-2029)
  • FIGURE 15 ADVANCEMENTS IN SYNTHETIC BIOLOGY AND RISING DEMAND FOR BIO-BASED PRODUCTS TO DRIVE MARKET
  • FIGURE 16 MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 17 MEDICAL APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 18 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 19 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 21 SYNTHETIC BIOLOGY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 SYNTHETIC BIOLOGY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 SYNTHETIC BIOLOGY MARKET: PATENT ANALYSIS, 2013–2023
  • FIGURE 24 SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 27 NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET, 2019–2023 (USD MILLION)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET, 2023
  • FIGURE 31 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 32 SYNTHETIC BIOLOGY MARKET: COMPANY FOOTPRINT
  • FIGURE 33 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 34 EV/EBITDA OF KEY VENDORS, 2023
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 36 SYNTHETIC BIOLOGY MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 39 NOVOZYMES A/S: COMPANY SNAPSHOT (2023)
  • FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 42 CODEXIS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 43 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)
  • FIGURE 44 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 45 PRECIGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 46 GINKGO BIOWORKS: COMPANY SNAPSHOT (2023)

The research study involved the wide use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global synthetic biology market. Extensive interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size is estimated through secondary research (top-down and bottom-up) followed by data triangulation with inputs from industry experts to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the technical, market-oriented, and commercial study of the synthetic biology market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), Lens.org, National Center for Biotechnology Information (NCBI), Imperial College Centre for Synthetic Biology, Institute of Systems & Synthetic Biology (iSSB), University of California San Francisco (UCSF), Center for Systems and Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Engineering Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Biotechnology and Biological Sciences Research Council (BBSRC), Helmholtz Association of German Research Centres, Asian Synthetic Biology Association, World Bank, Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations among others. These secondary sources were also used to obtain major information about key market players, and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analysed to arrive at the market size of the global synthetic biology market, which was further validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global synthetic biology market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biopharmaceutical industries from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. The primary interviews were conducted across six major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the synthetic biology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Synthetic biology involves the redesign of natural biological systems by engineering and designing new biological parts and functions, namely synthetic biological pathways and organisms, which are used to construct end products. It is an innovative research area broadly comprising of multiple disciplines, such as biotechnology, molecular biology, genetic engineering, and biophysics, among others.

Stakeholders

  • Companies Providing Synthetic Biology Tools, Technologies, and Related Products & Services
  • Research Institutes and Academic Centers
  • Suppliers and Distributors of Synthetic Biology Tools & Technologies
  • Pharmaceutical and Biotechnology Companies
  • Agricultural and Veterinary companies
  • Business Research and Consulting Service Providers
  • Venture Capitalists
  • Contract Research Organizations and Contract Development Manufacturing Organizations
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the synthetic biology market by value by tool, technology, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall Synthetic biology market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Previous Versions of this Report

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027

Report Code BT 2910
Published in Feb, 2023, By MarketsandMarkets™

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Gene Synthesis, Genome Engineering), Application(Tissue Regeneration, Biofuel, Consumer Care, Food & Agriculture, Environmental) and Region - Global Forecast to 2026

Report Code BT 2910
Published in May, 2021, By MarketsandMarkets™

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) - Global Forecast to 2025

Report Code BT 2910
Published in Feb, 2020, By MarketsandMarkets™

Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022

Report Code BT 2910
Published in Dec, 2017, By MarketsandMarkets™

Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

Report Code BT 2910
Published in Nov, 2014, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Synthetic Biology Market

Meghan

Dec, 2022

Can you elaborate more on the emerging trends in the global Synthetic Biology Market?.

Kenny

Dec, 2022

Which growth strategies are adopted by key players in the global Synthetic Biology Market?.

John

May, 2022

This article looks interesting. I would like to know how many primary and secondary interviews were conducted for data validation on Synthetic Biology Market..

Billy

Mar, 2022

Can you share the detailed information on key factors Driving the growth of Global Synthetic Biology Market?.

Joe

Mar, 2022

How much share does the top companies holds, of global Synthetic Biology Market?.

Bruce

Mar, 2022

Can you elaborate more on the global geographical growth scenario for the Synthetic Biology Market?.

DMCA.com Protection Status